Falk Gastro Info 11/2025

Video course abdominal ultrasound

Examination of the gastrointestinal tract – Ileocecal region, ascending colon

Author: Prof. Dr. Christoph F. Dietrich

©Falk Foundation e.V., Freiburg. All rights reserved.

Please switch on your loudspeakers!
Link to Falk Mediacenter
Latest research in brief:
Image
Colon to Rectum
Text:

Cercek A et al, N Engl J Med. 2025;392(23):2297-2308

Nonoperative management of mismatch repair-deficient (dMMR) tumors: Among patients with early-stage dMMR rectal and non-rectal tumors that were amenable to curative-intent surgery, neoadjuvant PD-1 blockade led to organ preservation in a high proportion of patients.

Link to Falk Mediacenter

Drews J et al, Gut. 2025;74(7):1103-1111

Self-assembling haemostatic gel to prevent delayed bleeding following endoscopic mucosal resection (EMR): The application of a haemostatic gel following EMR of large flat lesions in the duodenum and colorectum did not reduce the rate of delayed bleeding in a prospective multicenter trial (PURPLE).

Link to Falk Mediacenter
Image
Liver and Bile Ducts
Text:

Larson EL et al, J Hepatol. 2025;83(3):729-737

Liver transplantation and obesity – Combined bariatric surgery shows benefits; A U.S. study reports positive outcomes of performing bariatric surgery combined with liver transplantation. In this retrospective analysis, 72 patients who underwent combined liver transplantation and sleeve gastrectomy achieved more pronounced and sustained weight loss, reduced graft steatosis, and improved metabolic profiles compared to 185 patients receiving transplantation alone. Although no significant differences in overall mortality or graft survival were observed during the follow-up period, the findings highlight a promising strategy for the growing population of obese liver transplant candidates.

Link to Falk Mediacenter
Text:

Trickey A et al, Lancet Gastroenterol Hepatol. 2025;10(10):904-914

Vertical transmission of hepatitis C virus (HCV) remains a global concern: A global modelling study estimates that around 74,000 children worldwide are infected with HCV each year through vertical transmission. Based on the well-founded assumption that two-thirds of these children will spontaneously clear the virus by the age of five, approximately 23,000 chronic HCV infections arise annually from mother-to-child transmission. Southern Asia and Africa are particularly affected. The study highlights the need to implement HCV screening and antiviral therapy during pregnancy.

Link to Falk Mediacenter
Image
Esophagus to Small Intestine
Text:

Tan WK et al, Lancet. 2025;406(10500):271-282

Monitoring of Barrett's esophagus using a capsule sponge test: The collection of esophageal tissue using a sponge attached to a capsule and subsequent biomarker analysis allowed a reliable diagnosis of dysplastic alterations in a prospective British study and could be used in lieu of endoscopy in low-risk Barrett's patients.

Link to Falk Mediacenter
Text:

Hart A et al, Gastroenterology. 2025;169(2):308-325

Subcutaneous induction therapy with guselkumab in Crohn's disease (GRAVITI): Subcutaneous induction and maintenance therapy with the IL-23 antibody guselkumab was significantly more effective than placebo in a phase 3 trial enrolling patients with moderately to severely active Crohn's disease and achieved comparable clinical outcomes as in previous trials with intravenous induction therapy.

Link to Falk Mediacenter
Image
Pancreas
Text:

Mahajan UM et al, Lancet Gastroenterol Hepatol. 2025;10(7):634-647

Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): Two plasma-based metabolic signatures showed significant improvement in performance compared with CA 19-9 alone in excluding pancreatic ductal adenocarcinoma in a prospective real-world cohort of patients with pancreatic lesions requiring further diagnostic assessment.

Link to Falk Mediacenter

Symposium 242

Advances in Hepatology – from Mechanistic Insights to Novel Therapeutic Concepts

October 24 – 25, 2025, Berlin Germany

JW Marriott Hotel Berlin, Stauffenbergstr. 26, 10785 Berlin, Germany

Program
Registration

Symposium

Next Gen Liver Immunology: Bridging Basic Science and Clinical Practice

February 5 – 6, 2026, Freiburg, Germany

Konzerthaus Freiburg, Konrad-Adenauer-Platz 1, 79098 Freiburg im Breisgau, Germany

Program
Registration

Symposium 243

Gastrointestinal Inflammation and Neoplasia

April 24 – 25, 2026, Warsaw, Poland

Hilton Warsaw City, Grzybowska 63, 00-844 Warsaw, Poland

Program
Registration

Current Falk literature:

Falk News

Falk News

Symposium 241: Mucosal Immunology Days

Oxford (United Kingdom), July 10 – 12, 2025

(6 pages)

FN241